A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

Clinical trial NCT06939504 · COMPLETED

Trial details

NCT number: NCT06939504
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Fibrosis

Start date: 2025-05-04
Primary completion: 2025-06-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.